BeOne Medicines Ltd. (ONC): EBITDA
$588.82M
Year ended 2025-12-31
$1.08B
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $588.82M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$396.44M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$1.12B | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$1.72B | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.39B | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$1.63B | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$941.27M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$695.38M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$93.70M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$115.15M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$55.20M | n/a | 2018-02-28, From 2015-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $588.82M | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$388.64M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$784.70M | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $557.24M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $489.04M | -15.8% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.58B | +8.9% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $3.02B | +7.4% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $4.38B | n/m |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$655.26M | n/m |
Compare ONC, JAZZ, PRGO, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗